Earnings results for Applied DNA Sciences (NASDAQ:APDN)
Applied DNA Sciences, Inc. is expected* to report earnings on 02/11/2021 after market close. The report will be for the fiscal Quarter ending Dec 2020. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.55. The reported EPS for the same quarter last year was $-1.12.
Applied DNA Sciences last announced its quarterly earnings results on December 16th, 2020. The technology company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.52) by $0.26. The company had revenue of $0.31 million for the quarter, compared to analysts’ expectations of $0.70 million. Applied DNA Sciences has generated ($3.32) earnings per share over the last year. Applied DNA Sciences has confirmed that its next quarterly earnings report will be published on Thursday, February 11th, 2021.
Analyst Opinion on Applied DNA Sciences (NASDAQ:APDN)
2 Wall Street analysts have issued ratings and price targets for Applied DNA Sciences in the last 12 months. Their average twelve-month price target is $17.50, predicting that the stock has a possible upside of 43.09%. The high price target for APDN is $21.00 and the low price target for APDN is $14.00. There are currently 2 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Applied DNA Sciences has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $17.50, Applied DNA Sciences has a forecasted upside of 43.1% from its current price of $12.23. Applied DNA Sciences has only been the subject of 1 research reports in the past 90 days.
Dividend Strength: Applied DNA Sciences (NASDAQ:APDN)
Applied DNA Sciences does not currently pay a dividend. Applied DNA Sciences does not have a long track record of dividend growth.
Insiders buying/selling: Applied DNA Sciences (NASDAQ:APDN)
In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock. Only 6.60% of the stock of Applied DNA Sciences is held by insiders. Only 7.04% of the stock of Applied DNA Sciences is held by institutions.
Earnings and Valuation of Applied DNA Sciences (NASDAQ:APDN
The P/E ratio of Applied DNA Sciences is -3.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Applied DNA Sciences is -3.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Applied DNA Sciences has a P/B Ratio of 11.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here